The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota
Abstract
Background: Chronic rhinosinusitis (CRS) is a common and debilitating inflammatory condition of the sinuses, afflicting 5% of the general population. Although antibiotics are frequently prescribed for the medical management of CRS, there is surprisingly little evidence to support their efficacy. In this study, we aimed to establish associations between medication usage, the sinus microbiota and patients’ clinical outcomes. Methods: Antibiotic prescription patterns for the year before sample collection of 156 CRS patients, 45 disease control patients (mostly requiring septoplasty and inferior turbinate reduction) and 35 healthy control subjects were examined and analyzed together with previously published bacterial 16S rRNA gene amplicon data from our group. Results: The highest antibiotic usage was observed among the two CRS patient categories. Despite heavy antibiotic usage, CRS patients’ clinical outcomes as indicated by patient questionnaires and radiologic scores were similar to those patients that did not receive any antibiotics. The sinus microbiota was dominated by members of the bacterial genera Corynebacterium and Staphylococcus in all three cohorts. Bacterial community dispersion as measured by principal coordinate analysis was significantly higher in CRS patients compared to healthy control subjects, but not disease control patients. Pairwise comparisons within cohorts revealed differences in the relative 16S rRNA gene sequence abundances of the genera Staphylococcus and Lawsonella between antibiotic users and non-users. However, overall antibiotic effects were minimal and unpredictable. Conclusion: The unpredictable effects of antibiotic treatment on the sinus microbiota found in this study, together with the lack of differences in patients’ symptom scores between cohorts, do not support preoperative antibiotic treatment for CRS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among those, Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa) biofilms are most commonly observed and directly influential in shaping the severity of CRS [13,17,18,19,20,21].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Self-citationInternational Consensus Statement on Allergy and Rhinology: Rhinosinusitis
Orlandi, R. R., Kingdom, T. T., Hwang, P. H., Smith, T. L., Alt, J. A., Baroody, F. M., Batra, P. S., Bernal‐Sprekelsen, M., Bhattacharyya, N., Chandra, R. K., et al. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21695 · Cited by 892
Self-citationDecade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599
Abreu, N. A., Nagalingam, N. A., Song, Y., Roediger, F. C., Pletcher, S. D., Goldberg, A. N., & Lynch, S. V. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003783 · Cited by 415
Research works printed but not linked: 59
- Akkerman, 2005, Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics., Br. J. Gen. Pract., 55, 114
- Bachert, 2014, ICON: chronic rhinosinusitis., World Allergy Organ., 7, 1, 10.1186/1939-4551-7-25 · DOI · Paper page
- Barshak, 2017, The role of infection and antibiotics in chronic rhinosinusitis., Laryngosc. Investig. Otolaryngol., 2, 36, 10.1002/lio2.61 · DOI
- Beule, 2015, Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden., GMS Curr. Top. Otorhinolaryngol. Head Neck Surg., 14, 10.3205/cto000126 · DOI
- Biswas, 2019, Comparison of subtyping approaches and the underlying drivers of microbial signatures for chronic rhinosinusitis., mSphere, 4, 10.1128/mSphere.00679-18 · DOI
- Biswas, 2015, The nasal microbiota in health and disease: variation within and between subjects., Front. Microbiol., 9, 10.3389/fmicb.2015.00134 · DOI · Paper page
- Biswas, 2017, Differentially regulated host proteins associated with chronic rhinosinusitis are correlated with the sinonasal microbiome., Front. Cell. Infect. Microbiol., 7, 10.3389/fcimb.2017.00504 · DOI
- Brook, 2017, Chronic Sinusitis Medication [Online].
- Cain, 2013, Update on the management of chronic rhinosinusitis., Infect. Drug Resist., 6, 1, 10.2147/IDR.S26134 · DOI
- Callahan, 2016, DADA2: high-resolution sample inference from illumina amplicon data., Nat. Methods, 13, 581, 10.1038/nmeth.3869 · DOI · Paper page
- Chalermwatanachai, 2018, Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota., Sci. Rep., 8, 10.1038/s41598-018-26327-2 · DOI
- Chandy, 2019, Clinical guidelines on chronic rhinosinusitis in children., Curr. Allergy Asthma Rep., 19, 10.1007/s11882-019-0845-7 · DOI
- Cheng, 2015, The role of macrolide antibiotics in increasing cardiovascular risk., J. Am. Coll. Cardiol., 66, 2173, 10.1016/j.jacc.2015.09.029 · DOI
- Dietz de Loos, 2019, Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology., J. Allergy Clin. Immunol., 143, 1207, 10.1016/j.jaci.2018.12.986 · DOI · Paper page
- Dubin, 2007, American rhinologic society member survey on “maximal medical therapy” for chronic rhinosinusitis., Am. J. Rhinol., 21, 483, 10.2500/ajr.2007.21.3047 · DOI
- Escapa, 2018, New insights into human nostril microbiome from the expanded human oral microbiome database (eHOMD): a resource for the microbiome of the human aerodigestive tract., mSystems, 3, 10.1128/mSystems.00187-18 · DOI · Paper page
- Fodor, 2012, The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations., PLoS One, 7, 10.1371/journal.pone.0045001 · DOI · Paper page
- Gulliford, 2014, Continued high rates of antibiotic prescribing to adults with respiratory tract infection: survey of 568 uk general practices., BMJ Open, 4, 10.1136/bmjopen-2014-006245 · DOI · Paper page
- Head, 2016, Systemic and topical antibiotics for chronic rhinosinusitis., Cochrane Database Syst. Rev., 4, 10.1002/14651858.CD011994.pub2 · DOI
- Hoggard, Evidence of microbiota dysbiosis in chronic rhinosinusitis., Int. Forum Allergy Rhinol., 7, 230, 10.1002/alr.21871 · DOI · Paper page
- Hoggard, Chronic rhinosinusitis and the evolving understanding of microbial ecology in chronic inflammatory mucosal disease., Clin. Microbiol. Rev., 30, 321, 10.1128/CMR.00060-16 · DOI
- Hwang, 2019, Prevalence and risk factors of chronic rhinosinusitis in the elderly population of Korea., Am. J. Rhinol. Allergy, 33, 240, 10.1177/1945892418813822 · DOI
- Jain, 2018, The effect of medical treatments on the bacterial microbiome in patients with chronic rhinosinusitis: a pilot study., Int. Forum Allergy Rhinol., 10.1002/alr.22110 · DOI
- Jernberg, 2010, Long-term impacts of antibiotic exposure on the human intestinal microbiota., Microbiology, 156, 3216, 10.1099/mic.0.040618-0 · DOI · Paper page
- Kennedy, 2013, Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly., Am. J. Rhinol. Allergy, 27, 467, 10.2500/ajra.2013.27.3960 · DOI
- Khan, 2019, Commensal bacteria: an emerging player in defense against respiratory pathogens., Front. Immunol., 10, 10.3389/fimmu.2019.01203 · DOI · Paper page
- Kim, 2015, Paired analysis of the microbiota of surface mucus and whole-tissue specimens in patients with chronic rhinosinusitis., Int. Forum Allergy Rhinol., 5, 877, 10.1002/alr.21600 · DOI
- Klindworth, 2013, Evaluation of general 16s ribosomal rna gene pcr primers for classical and next-generation sequencing-based diversity studies., Nucleic Acids Res., 41, 10.1093/nar/gks808 · DOI · Paper page
- Lim, 2008, Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review., Am. J. Rhinol., 22, 381, 10.2500/ajr.2008.22.3189 · DOI
- Lim, 2014, Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis., J. Clin. Microbiol., 52, 425, 10.1128/JCM.02204-13 · DOI
- Liu, 2013, Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis., Int. Forum Allergy Rhinol., 3, 775, 10.1002/alr.21195 · DOI
- Lodato, 2013, Priority Medicines for Europe and the World “a Public Health Approach to Innovation”: Background Paper 6.1 Antimicrobial Resistance.
- Lux, 2020, Efficacy of neutral electrolysed water in postoperative chronic rhinosinusitis patients., Int. Forum Allergy Rhinol., 10.1002/alr.22683 · DOI
- Malaty, 2016, Medical management of chronic rhinosinusitis in adults., Sinusitis, 1, 76, 10.3390/sinusitis1010076 · DOI
- Mangiafico, 2019, Rcompanion: Functions to Support Extension Education Program Evaluation.
- Maxfield, 2017, General antibiotic exposure is associated with increased risk of developing chronic rhinosinusitis., Laryngoscope, 127, 296, 10.1002/lary.26232 · DOI
- McMurdie, 2013, Phyloseq: an r package for reproducible interactive analysis and graphics of microbiome census data., PLoS One, 8, 10.1371/journal.pone.0061217 · DOI · Paper page
- Musa, 2019, Antibiotic sensitivity pattern of bacterial isolates in patients with chronic rhinosinusitis in Kaduna, Nigeria., Int. Arch. Otorhinolaryngol., 23, 152, 10.1055/s-0038-1673676 · doi:10.1055/s-0038-1673676
- Oksanen, 2019, Vegan: Community Ecology Package.
- Paramasivan, 2019, The international sinonasal microbiome study (ISMS): a multicentre, international characterization of sinonasal bacterial ecology., Allergy, 2020, 2033, 10.1111/all.14276 · DOI
- Parasher, 2019, The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps., Am. J. Otolaryngol., 40, 467, 10.1016/j.amjoto.2019.03.004 · DOI
- Quast, 2013, The silva ribosomal rna gene database project: improved data processing and web-based tools., Nucleic Acids Res., 41, 590, 10.1093/nar/gks1219 · DOI · Paper page
- 2019, R: A Language and Environment for Statistical Computing.
- Rom, 2019, The association between disease severity and microbiome in chronic rhinosinusitis., Laryngoscope, 129, 1265, 10.1002/lary.27726 · DOI
- Rosenfeld, 2015, Clinical practice guideline (update): adult sinusitis., Otolaryngol. Head Neck Surg., 1, 10.1177/0194599815572097 · DOI · Paper page
- Schwartz, 2016, Medical management of chronic rhinosinusitis - an update., Expert Rev. Clin. Pharmacol., 9, 695, 10.1586/17512433.2016.1150780 · DOI
- Segata, 2011, Metagenomic biomarker discovery and explanation., Genome Biol., 12, 10.1186/gb-2011-12-6-r60 · DOI · Paper page
- Shreiner, 2015, The gut microbiome in health and in disease., Curr. Opin. Gastroenterol., 31, 69, 10.1097/MOG.0000000000000139 · DOI · Paper page
- Smith, 2013, National burden of antibiotic use for adult rhinosinusitis., J. Allergy Clin. Immunol., 132, 1230, 10.1016/j.jaci.2013.07.009 · DOI
- Sturm, 2019, Infection with lawsonella clevelandensis is easily overlooked using routine microbiology methods: a case of a surgical mesh-associated abscess., Clin. Microbiol., 8
- Varvyanskaya, 2014, Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery., Int. Forum Allergy Rhinol., 4, 533, 10.1002/alr.21318 · DOI
- Wagner Mackenzie, Detection and quantification of Staphylococcus in chronic rhinosinusitis., Int. Forum Allergy Rhinol., 9, 1462, 10.1002/alr.22425 · DOI
- Wagner Mackenzie, Longitudinal study of the bacterial and fungal microbiota in the human sinuses reveals seasonal and annual changes in diversity., Sci. Rep., 9, 10.1038/s41598-019-53975-9 · DOI
- Wagner Mackenzie, 2017, Bacterial community collapse: a meta-analysis of the sinonasal microbiota in chronic rhinosinusitis., Environ. Microbiol., 19, 381, 10.1111/1462-2920.13632 · DOI · Paper page
- Walker, 2019, What is the most appropriate treatment for chronic rhinosinusitis?, Postgrad. Med. J., 95, 493, 10.1136/postgradmedj-2019-136519 · DOI
- Wallwork, 2006, A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis., Laryngoscope, 116, 189, 10.1097/01.mlg.0000191560.53555.08 · DOI · Paper page
- Winkel, 2015, Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10 years in the claricor randomised, blinded clinical trial., Int. J. Cardiol., 182, 459, 10.1016/j.ijcard.2015.01.020 · DOI
- Wood, 2017, Effectiveness of extensive sinus surgery with post-operative medical management for chronic rhinosinusitis., J. Laryngol. Otol., 131, S19, 10.1017/S0022215116009361 · DOI
- Zeng, 2011, Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in chinese adults., Am. J. Rhinol. Allergy, 25, 203, 10.2500/ajra.2011.25.3728 · DOI
Cited by
Antibiotic failure: Beyond antimicrobial resistance
de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 254
Yathavan, B., Chhibber, T., Steinhauff, D., Pulsipher, A., Alt, J. A., Ghandehari, H., & Jafari, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102426 · Cited by 20
Metadata
- Authors
- Lux, C. A., Wagner Mackenzie, B., Johnston, J., Zoing, M., Biswas, K., Taylor, M. W., & Douglas, R. G.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-22
- Volume
- 11
- ISSN
- 1664-302X
- Cited by
- 36
- References
- 4
- Funders
- Garnett Passe and Rodney Williams Memorial Foundation (91073712790)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.